Drug-induced localized systemic scleroses.
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D006801:Humans; D008784:Methysergide / Q000009:adverse effects*; D008790:Metoprolol / Q000009:adverse effects; D011217:Practolol / Q000009:adverse effects; D011433:Propranolol / Q000009:adverse effects; D012595:Scleroderma, Systemic / Q000139:chemically induced* / Q000473:pathology
D000319:Adrenergic beta-Antagonists; D011433:Propranolol; D008790:Metoprolol; D011217:Practolol; D008784:Methysergide